Household & Personal Products
Compare Stocks
5 / 10Stock Comparison
GROV vs PRGO vs CHD vs HLN vs PG
Revenue, margins, valuation, and 5-year total return — side by side.
Drug Manufacturers - Specialty & Generic
Household & Personal Products
Drug Manufacturers - Specialty & Generic
Household & Personal Products
GROV vs PRGO vs CHD vs HLN vs PG — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Household & Personal Products | Drug Manufacturers - Specialty & Generic | Household & Personal Products | Drug Manufacturers - Specialty & Generic | Household & Personal Products |
| Market Cap | $52M | $1.61B | $22.24B | $41.45B | $341.30B |
| Revenue (TTM) | $166M | $4.18B | $6.21B | $22.01B | $86.72B |
| Net Income (TTM) | $-9M | $-1.82B | $733M | $3.18B | $12.72B |
| Gross Margin | 54.1% | 34.2% | 45.1% | 63.9% | 50.3% |
| Operating Margin | -2.6% | -4.1% | 17.3% | 21.4% | 23.2% |
| Forward P/E | — | 5.6x | 25.0x | 22.2x | 21.1x |
| Total Debt | $20M | $3.97B | $2.21B | $8.59B | $35.46B |
| Cash & Equiv. | $8M | $532M | $409M | $1.32B | $9.56B |
GROV vs PRGO vs CHD vs HLN vs PG — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Jul 22 | May 26 | Return |
|---|---|---|---|
| Grove Collaborative… (GROV) | 100 | 5.8 | -94.2% |
| Perrigo Company plc (PRGO) | 100 | 28.0 | -72.0% |
| Church & Dwight Co.… (CHD) | 100 | 106.7 | +6.7% |
| Haleon plc (HLN) | 100 | 132.4 | +32.4% |
| The Procter & Gambl… (PG) | 100 | 105.1 | +5.1% |
Price return only. Dividends and distributions are not included.
Quick Verdict: GROV vs PRGO vs CHD vs HLN vs PG
Each card shows where this stock fits in a portfolio — not just who wins on paper.
GROV ranks third and is worth considering specifically for momentum.
- +6.0% vs PRGO's -51.2%
PRGO has the current edge in this matchup, primarily because of its strength in defensive.
- Beta 1.18, yield 9.8%, current ratio 2.76x
- Lower P/E (5.6x vs 21.1x)
- 9.8% yield, 10-year raise streak, vs PG's 2.8%, (1 stock pays no dividend)
CHD is the clearest fit if your priority is growth exposure.
- Rev growth 1.6%, EPS growth 27.4%, 3Y rev CAGR 4.9%
- 1.6% revenue growth vs GROV's -14.6%
HLN is the #2 pick in this set and the best alternative if sleep-well-at-night and valuation efficiency is your priority.
- Lower volatility, beta 0.06, Low D/E 52.2%, current ratio 0.92x
- PEG 2.63 vs PG's 3.78
- Beta 0.06 vs PRGO's 1.18, lower leverage
- 10.0% ROA vs PRGO's -19.8%, ROIC 7.6% vs 3.7%
PG is the clearest fit if your priority is income & stability and long-term compounding.
- Dividend streak 36 yrs, beta 0.10, yield 2.8%
- 119.3% 10Y total return vs HLN's 31.7%
- 14.7% margin vs PRGO's -43.5%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 1.6% revenue growth vs GROV's -14.6% | |
| Value | Lower P/E (5.6x vs 21.1x) | |
| Quality / Margins | 14.7% margin vs PRGO's -43.5% | |
| Stability / Safety | Beta 0.06 vs PRGO's 1.18, lower leverage | |
| Dividends | 9.8% yield, 10-year raise streak, vs PG's 2.8%, (1 stock pays no dividend) | |
| Momentum (1Y) | +6.0% vs PRGO's -51.2% | |
| Efficiency (ROA) | 10.0% ROA vs PRGO's -19.8%, ROIC 7.6% vs 3.7% |
GROV vs PRGO vs CHD vs HLN vs PG — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
GROV vs PRGO vs CHD vs HLN vs PG — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
PG leads in 2 of 6 categories
PRGO leads 1 • HLN leads 1 • GROV leads 0 • CHD leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
PG leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
PG is the larger business by revenue, generating $86.7B annually — 521.2x GROV's $166M. PG is the more profitable business, keeping 14.7% of every revenue dollar as net income compared to PRGO's -43.5%. On growth, PG holds the edge at +7.4% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $166M | $4.2B | $6.2B | $22.0B | $86.7B |
| EBITDAEarnings before interest/tax | -$3M | $58M | $1.3B | $5.3B | $21.9B |
| Net IncomeAfter-tax profit | -$9M | -$1.8B | $733M | $3.2B | $12.7B |
| Free Cash FlowCash after capex | -$2M | $108M | $1.1B | $3.1B | $15.0B |
| Gross MarginGross profit ÷ Revenue | +54.1% | +34.2% | +45.1% | +63.9% | +50.3% |
| Operating MarginEBIT ÷ Revenue | -2.6% | -4.1% | +17.3% | +21.4% | +23.2% |
| Net MarginNet income ÷ Revenue | -5.5% | -43.5% | +11.8% | +14.5% | +14.7% |
| FCF MarginFCF ÷ Revenue | -1.0% | +2.6% | +17.2% | +14.2% | +17.3% |
| Rev. Growth (YoY)Latest quarter vs prior year | -16.8% | -7.2% | +0.1% | -0.4% | +7.4% |
| EPS Growth (YoY)Latest quarter vs prior year | +70.0% | -56.4% | +2.2% | +18.8% | +5.8% |
Valuation Metrics
PRGO leads this category, winning 4 of 7 comparable metrics.
Valuation Metrics
At 19.0x trailing earnings, HLN trades at a 39% valuation discount to CHD's 31.1x P/E. Adjusting for growth (PEG ratio), HLN offers better value at 2.25x vs PG's 4.01x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $52M | $1.6B | $22.2B | $41.4B | $341.3B |
| Enterprise ValueMkt cap + debt − cash | $64M | $5.1B | $24.0B | $51.3B | $367.2B |
| Trailing P/EPrice ÷ TTM EPS | -3.62x | -1.14x | 31.09x | 19.01x | 22.44x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 5.56x | 25.01x | 22.22x | 21.14x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | 2.25x | 4.01x |
| EV / EBITDAEnterprise value multiple | — | 7.42x | 18.14x | 13.62x | 15.76x |
| Price / SalesMarket cap ÷ Revenue | 0.30x | 0.38x | 3.59x | 2.83x | 4.05x |
| Price / BookPrice ÷ Book value/share | 6.18x | 0.55x | 5.73x | 1.87x | 6.86x |
| Price / FCFMarket cap ÷ FCF | — | 11.12x | 20.35x | 15.47x | 24.30x |
Profitability & Efficiency
PG leads this category, winning 4 of 9 comparable metrics.
Profitability & Efficiency
PG delivers a 23.8% return on equity — every $100 of shareholder capital generates $24 in annual profit, vs $-106 for GROV. HLN carries lower financial leverage with a 0.52x debt-to-equity ratio, signaling a more conservative balance sheet compared to GROV's 2.63x. On the Piotroski fundamental quality scale (0–9), HLN scores 8/9 vs GROV's 3/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -106.3% | -50.7% | +17.4% | +19.9% | +23.8% |
| ROA (TTM)Return on assets | -16.9% | -19.8% | +8.2% | +10.0% | +10.0% |
| ROICReturn on invested capital | -31.7% | +3.7% | +13.9% | +7.6% | +20.1% |
| ROCEReturn on capital employed | -25.6% | +4.3% | +14.4% | +8.6% | +23.0% |
| Piotroski ScoreFundamental quality 0–9 | 3 | 4 | 7 | 8 | 5 |
| Debt / EquityFinancial leverage | 2.63x | 1.35x | 0.55x | 0.52x | 0.68x |
| Net DebtTotal debt minus cash | $12M | $3.4B | $1.8B | $7.3B | $25.9B |
| Cash & Equiv.Liquid assets | $8M | $532M | $409M | $1.3B | $9.6B |
| Total DebtShort + long-term debt | $20M | $4.0B | $2.2B | $8.6B | $35.5B |
| Interest CoverageEBIT ÷ Interest expense | -3.79x | -7.20x | 15.59x | 7.80x | 487.21x |
Total Returns (Dividends Reinvested)
HLN leads this category, winning 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in HLN five years ago would be worth $13,169 today (with dividends reinvested), compared to $250 for GROV. Over the past 12 months, GROV leads with a +6.0% total return vs PRGO's -51.2%. The 3-year compound annual growth rate (CAGR) favors HLN at 3.4% vs PRGO's -25.2% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +9.8% | -13.5% | +14.0% | -5.6% | +4.5% |
| 1-Year ReturnPast 12 months | +6.0% | -51.2% | +3.4% | -11.7% | -5.6% |
| 3-Year ReturnCumulative with dividends | -48.9% | -58.1% | +0.7% | +10.4% | +1.9% |
| 5-Year ReturnCumulative with dividends | -97.5% | -60.1% | +13.7% | +31.7% | +22.4% |
| 10-Year ReturnCumulative with dividends | -97.5% | -77.7% | +113.6% | +31.7% | +119.3% |
| CAGR (3Y)Annualised 3-year return | -20.0% | -25.2% | +0.2% | +3.4% | +0.6% |
Risk & Volatility
Evenly matched — CHD and HLN each lead in 1 of 2 comparable metrics.
Risk & Volatility
HLN is the less volatile stock with a 0.06 beta — it tends to amplify market swings less than PRGO's 1.18 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CHD currently trades 88.5% from its 52-week high vs PRGO's 41.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.14x | 1.18x | 0.14x | 0.06x | 0.10x |
| 52-Week HighHighest price in past year | $1.84 | $28.44 | $106.04 | $11.42 | $170.99 |
| 52-Week LowLowest price in past year | $1.03 | $9.23 | $81.33 | $8.71 | $137.62 |
| % of 52W HighCurrent price vs 52-week peak | +66.8% | +41.2% | +88.5% | +81.5% | +85.4% |
| RSI (14)Momentum oscillator 0–100 | 49.1 | 60.9 | 49.1 | 36.0 | 53.7 |
| Avg Volume (50D)Average daily shares traded | 81K | 3.4M | 1.8M | 8.0M | 7.2M |
Analyst Outlook
Evenly matched — PRGO and PG each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: PRGO as "Hold", CHD as "Buy", HLN as "Buy", PG as "Buy". Consensus price targets imply 70.6% upside for PRGO (target: $20) vs 6.1% for CHD (target: $100). For income investors, PRGO offers the higher dividend yield at 9.81% vs CHD's 1.25%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Hold | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | — | $20.00 | $99.60 | $10.20 | $161.88 |
| # AnalystsCovering analysts | — | 36 | 34 | 4 | 52 |
| Dividend YieldAnnual dividend ÷ price | — | +9.8% | +1.3% | +1.9% | +2.8% |
| Dividend StreakConsecutive years of raises | — | 10 | 23 | 2 | 36 |
| Dividend / ShareAnnual DPS | — | $1.15 | $1.18 | $0.13 | $4.02 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% | +4.0% | +2.1% | +1.9% |
PG leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). PRGO leads in 1 (Valuation Metrics). 2 tied.
GROV vs PRGO vs CHD vs HLN vs PG: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is GROV or PRGO or CHD or HLN or PG a better buy right now?
For growth investors, Church & Dwight Co.
, Inc. (CHD) is the stronger pick with 1. 6% revenue growth year-over-year, versus -14. 6% for Grove Collaborative Holdings, Inc. (GROV). Haleon plc (HLN) offers the better valuation at 19. 0x trailing P/E (22. 2x forward), making it the more compelling value choice. Analysts rate Church & Dwight Co. , Inc. (CHD) a "Buy" — based on 34 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — GROV or PRGO or CHD or HLN or PG?
On trailing P/E, Haleon plc (HLN) is the cheapest at 19.
0x versus Church & Dwight Co. , Inc. at 31. 1x. On forward P/E, Perrigo Company plc is actually cheaper at 5. 6x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Haleon plc wins at 2. 63x versus The Procter & Gamble Company's 3. 78x.
03Which is the better long-term investment — GROV or PRGO or CHD or HLN or PG?
Over the past 5 years, Haleon plc (HLN) delivered a total return of +31.
7%, compared to -97. 5% for Grove Collaborative Holdings, Inc. (GROV). Over 10 years, the gap is even starker: PG returned +119. 3% versus GROV's -97. 5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — GROV or PRGO or CHD or HLN or PG?
By beta (market sensitivity over 5 years), Haleon plc (HLN) is the lower-risk stock at 0.
06β versus Perrigo Company plc's 1. 18β — meaning PRGO is approximately 1833% more volatile than HLN relative to the S&P 500. On balance sheet safety, Haleon plc (HLN) carries a lower debt/equity ratio of 52% versus 3% for Grove Collaborative Holdings, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — GROV or PRGO or CHD or HLN or PG?
By revenue growth (latest reported year), Church & Dwight Co.
, Inc. (CHD) is pulling ahead at 1. 6% versus -14. 6% for Grove Collaborative Holdings, Inc. (GROV). On earnings-per-share growth, the picture is similar: Grove Collaborative Holdings, Inc. grew EPS 55. 3% year-over-year, compared to -723. 2% for Perrigo Company plc. Over a 3-year CAGR, CHD leads at 4. 9% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — GROV or PRGO or CHD or HLN or PG?
The Procter & Gamble Company (PG) is the more profitable company, earning 19.
0% net margin versus -33. 5% for Perrigo Company plc — meaning it keeps 19. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: PG leads at 24. 3% versus -4. 7% for GROV. At the gross margin level — before operating expenses — HLN leads at 64. 8%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is GROV or PRGO or CHD or HLN or PG more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Haleon plc (HLN) is the more undervalued stock at a PEG of 2. 63x versus The Procter & Gamble Company's 3. 78x. Both stocks trade at elevated growth-adjusted valuations, so expected growth needs to materialise. On forward earnings alone, Perrigo Company plc (PRGO) trades at 5. 6x forward P/E versus 25. 0x for Church & Dwight Co. , Inc. — 19. 4x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for PRGO: 70. 6% to $20. 00.
08Which pays a better dividend — GROV or PRGO or CHD or HLN or PG?
In this comparison, PRGO (9.
8% yield), PG (2. 8% yield), HLN (1. 9% yield), CHD (1. 3% yield) pay a dividend. GROV does not pay a meaningful dividend and should not be held primarily for income.
09Is GROV or PRGO or CHD or HLN or PG better for a retirement portfolio?
For long-horizon retirement investors, The Procter & Gamble Company (PG) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
10), 2. 8% yield, +119. 3% 10Y return). Both have compounded well over 10 years (PG: +119. 3%, GROV: -97. 5%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between GROV and PRGO and CHD and HLN and PG?
These companies operate in different sectors (GROV (Consumer Defensive) and PRGO (Healthcare) and CHD (Consumer Defensive) and HLN (Healthcare) and PG (Consumer Defensive)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: GROV is a small-cap quality compounder stock; PRGO is a small-cap income-oriented stock; CHD is a mid-cap quality compounder stock; HLN is a mid-cap quality compounder stock; PG is a large-cap quality compounder stock. PRGO, CHD, HLN, PG pay a dividend while GROV does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.